# Metastasis-directed Therapy for Oligometastases of Breast Cancer

> **NCT06135714** · PHASE3 · RECRUITING · sponsor: **Tokyo Medical and Dental University** · enrollment: 340 (estimated)

## Conditions studied

- Breast Cancer
- Oligometastasis
- Metastatic Breast Cancer

## Interventions

- **DRUG:** Systemic therapy for 12 weeks after primary registration
- **PROCEDURE:** Radiation therapy (SBRT/conventional RT)
- **PROCEDURE:** Surgery
- **DRUG:** Same systemic therapy after secondary registration

## Key facts

- **NCT ID:** NCT06135714
- **Lead sponsor:** Tokyo Medical and Dental University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-11-08
- **Primary completion:** 2026-11-08
- **Final completion:** 2032-10-31
- **Target enrollment:** 340 (ESTIMATED)
- **Last updated:** 2026-02-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06135714

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06135714, "Metastasis-directed Therapy for Oligometastases of Breast Cancer". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT06135714. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*